Orphan designation: alpibectir,ethionamide Treatment of tuberculosis Positive

Orphan designation: surovatamig Treatment of follicular lymphoma, 09/01/2026 Positive

Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation: 25/09/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Zirabev, bevacizumab, Date of authorisation: 14/02/2019, Revision: 19, Status: Authorised

Records of data processing activity on processing of personal data pertaining to staff absence

HMPC meeting report on European Union herbal monographs, guidelines and other activities - 2-4 March 2026

Revised rules for reimbursement of expenses for delegates attending meetings

Eltrombopag product-specific bioequivalence guidance

Decision of the Executive Director on the access to financial and administrative incentives for micro, small and medium-sized enterprises